Abstract
The development of anticancer drug delivery systems based on biodegradable nanoparticles has been intended to maximize the localization of chemotherapy agents within tumor interstitium, along with negligible drug distribution into healthy tissues. Interestingly, passive and active drug targeting strategies to cancer have led to improved nanomedicines with great tumor specificity and efficient chemotherapy effect. One of the most promising areas in the formulation of such nanoplatforms is the engineering of magnetically responsive nanoparticles. In this way, we have followed a chemical modification method for the synthesis of magnetite/chitosan-l-glutamic acid (core/shell) nanostructures. These magnetic nanocomposites (average size ≈340 nm) exhibited multifunctional properties based on its capability to load the antitumor drug doxorubicin (along with an adequate sustained release) and its potential for hyperthermia applications. Compared to drug surface adsorption, doxorubicin entrapment into the nanocomposites matrix yielded a higher drug loading and a slower drug release profile. Heating characteristics of the magnetic nanocomposites were investigated in a high-frequency alternating magnetic gradient: a stable maximum temperature of 46 °C was successfully achieved within 40 min. To our knowledge, this is the first time that such kind of stimuli-sensitive nanoformulation with very important properties (i.e., magnetic targeting capabilities, hyperthermia, high drug loading, and little burst drug release) has been formulated for combined antitumor therapy against cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ang KL, Venkatraman S, Ramanujan RV (2007) Magnetic PNIPA hydrogels for hyperthermia applications in cancer therapy. Mater Sci Eng C 27:347–351. doi:10.1016/j.msec.2006.05.027
Arias JL (2008) Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules 13:2340–2369. doi:10.3390/molecules13102340
Arias JL (2011) Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem 11:1–17. doi:10.2174/138955711793564024
Arias JL, Gallardo V, Gómez-Lopera SA, Plaza RC, Delgado AV (2001) Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. J Control Release 77:309–321. doi:10.1016/S0168-3659(01)00519-3
Arias JL, Gallardo V, Linares-Molinero F, Delgado AV (2006) Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles. J Colloid Interface Sci 299:599–607. doi:10.1016/j.jcis.2006.03.005
Arias JL, Gallardo V, Ruiz MA, Delgado AV (2007) Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres. Int J Pharm 337:282–290. doi:10.1016/j.ijpharm.2006.12.023
Arias JL, Reddy LH, Couvreur P (2008) Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. Langmuir 24:7512–7519. doi:10.1021/la800547s
Arias JL, Reddy LH, Couvreur P (2009) Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine. J Drug Target 17:586–598. doi:10.1080/10611860903105739
Arias JL, Martínez-Soler GI, López-Viota M, Ruiz MA (2010a) Formulation of chitosan nanoparticles loaded with metronidazole for the treatment of infectious diseases. Lett Drug Des Discov 7:70–78. doi:10.2174/157018010790225831
Arias JL, López-Viota M, Gallardo V, Ruiz MA (2010b) Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur. Drug Dev Ind Pharm 36:744–750. doi:10.3109/03639040903517914
Bodnar M, Hartmann JF, Borbely J (2005) Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6:2521–2527. doi:10.1021/bm0502258
Campbell RB (2007) Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat. Nanomedicine 2:649–652. doi:10.2217/17435889.2.5.649
Gaihre B, Khil MS, Lee DR, Kim HY (2009) Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study. Int J Pharm 365:180–189. doi:10.1016/j.ijpharm.2008.08.020
Huber DL (2005) Synthesis, properties, and applications of iron nanoparticles. Small 1:482–501. doi:10.1002/smll.200500006
Iannone A, Magin RL, Walczack T, Federico M, Swartz HM, Tomasi A, Vannini V (1991) Blood clearance of dextran magnetite particles determined by a noninvasive in vivo ESR method. Magn Reson Med 22:435–442. doi:10.1002/mrm.1910220251
Illum L (1998) Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326–1331. doi:10.1023/A:1011929016601
Ito A, Shinkai M, Honda H, Kobayashi T (2005) Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100:1–11. doi:10.1263/jbb.100.1
Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H, Deger S, Loening S, Lanksch W, Felix R (2001) Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 225:118–126. doi:10.1016/S0304-8853(00)01239-7
Kalele S, Narain R, Krishnan KM (2009) Probing temperature-sensitive behavior of pNIPAAm-coated iron oxide nanoparticles using frequency-dependent magnetic measurements. J Magn Magn Mater 321:1377–1380. doi:10.1016/j.jmmm.2009.02.134
Kallay N, Torbić Ž, Golić M, Matijević E (1991) Determination of the isoelectric points of several metals by an adhesion method. J Phys Chem 95:7028–7032. doi:10.1021/j100171a056
Lao LL, Ramanujan RV (2004) Magnetic and hydrogel composite materials for hyperthermia applications. J Mater Sci Mater Med 15:1061–1064. doi:10.1023/B:JMSM.0000046386.78633.e5
Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110. doi:10.1021/cr068445e
Llovet MI, Egea MA, Valero J, Alsina MA, García ML, Chauvet A (1995) Methotrexate-loaded nanoparticles: analysis of drug content and study of the matrix structure. Drug Dev Ind Pharm 21:1761–1771. doi:10.3109/03639049509069263
Lyklema J (2002) The role of surface conduction in the development of electrokinetics. In: Delgado AV (ed) Interfacial electrokinetics and electrophoresis. Marcel Dekker, New York, pp 87–98
Lyon RJP (1967) Infrared absorption spectroscopy. In: Zussman J (ed) Physical methods in determinative mineralogy. Academic Press, London/New York, pp 371–399
Massart R (1981) Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 17:1247–1248. doi:10.1109/TMAG.1981.1061188
Meers P (2001) Enzyme-activated targeting of liposomes. Adv Drug Deliv Rev 53:265–272. doi:10.1016/S0169-409X(01)00205-8
Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229. doi:10.1124/pr.56.2.6
Müller RH, Maaßen S, Weyhers H, Specht F, Lucks JS (1996) Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm 138:85–94. doi:10.1016/0378-5173(96)04539-5
Needham D, Dewhirst MW (2001) The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 53:285–305. doi:10.1016/S0169-409X(01)00233-2
Needham D, Anyarambhatla G, Kong G, Dewhirst MW (2000) A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 60:1197–1201
Nordtveit RJ, Vårum KM, Smidsrød O (1994) Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme. Carbohydr Polym 23:253–260. doi:10.1016/0144-8617(94)90187-2
O’Brien RW, White LR (1978) Electrophoretic mobility of a spherical colloidal particle. J Chem Soc Faraday Trans 2:1607–1626. doi:10.1039/F29787401607
Okon E, Pouliquen D, Okon P, Kovaleva ZV, Stepanova TP, Lavit SG, Kudryavtsev BN, Jallet P (1994) Biodegradation of magnetite dextran nanoparticles in the rat: a histologic and biophysical study. Lab Invest 71:895–903
Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M (2008) Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym 73:44–54. doi:10.1016/j.carbpol.2007.11.007
Pitt CG (1990) The controlled parenteral delivery of polypeptides and proteins. Int J Pharm 59:173–196. doi:10.1016/0378-5173(90)90108-G
Plaza RC, Arias JL, Espín M, Jiménez ML, Delgado AV (2002) Aging effects in the electrokinetics of colloidal iron oxides. J Colloid Interface Sci 245:86–90. doi:10.1006/jcis.2001.7964
Purushotham S, Ramanujan RV (2010) Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomater 6:502–510. doi:10.1016/j.actbio.2009.07.004
Rapoport N (2004) Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int J Pharm 277:155–162. doi:10.1016/j.ijpharm.2003.09.048
Regazzoni AE, Blesa MA, Maroto AJG (1983) Interfacial properties of zirconium dioxide and magnetite in water. J Colloid Interface Sci 91(2):560–570. doi:10.1016/0021-9797(83)90370-3
Ruiz MA, Gallardo V, Arias JL, Delgado A (2003) Effect of latex and plasticizer concentration on glucocorticoid release from ointments. Pharm Ind 65:454–457
Singh J, Dutta PK, Dutta J, Hunt AJ, Macquarrie DJ, Clark JH (2009) Preparation and properties of highly soluble chitosan-l-glutamic acid aerogel derivative. Carbohydr Polym 76:188–195. doi:10.1016/j.carbpol.2008.10.011
Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S (2004) Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1–33. doi:10.1016/j.ijpharm.2003.12.026
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70:1–20. doi:10.1016/S0168-3659(00)00339-4
Sun JB, Duan JH, Dai SL, Ren J, Zhang YD, Tian JS, Li Y (2007) In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers. Cancer Lett 258:109–117. doi:10.1016/j.canlet.2007.08.018
Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, Saida T, Honda H (2005) Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma. J Biosci Bioeng 100:112–115. doi:10.1263/jbb.100.112
Tashjian JA, Dewhirst MW, Needham D, Viglianti BL (2008) Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. Int J Hyperth 24:79–90. doi:10.1080/02656730701840147
Thanoo BC, Sunny MC, Jayakrishnan A (1992) Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J Pharm Pharmacol 44:283–286
Torchilin VP (2006) Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532–1555. doi:10.1016/j.addr.2006.09.009
van Oss CJ (2006) Interfacial forces in aqueous media, 2nd edn. CRC Press, Boca Raton, FL
Acknowledgments
Financial support from project PE2008-FQM-3993 (Junta de Andalucía) is acknowledged. D.P. Santos also gratefully acknowledges the financial support of FAPESP (research fellowship: process no. 2007/07914-7).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Santos, D.P., Ruiz, M.A., Gallardo, V. et al. Multifunctional antitumor magnetite/chitosan-l-glutamic acid (core/shell) nanocomposites. J Nanopart Res 13, 4311–4323 (2011). https://doi.org/10.1007/s11051-011-0378-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11051-011-0378-z